Inflammation - page 1 - Publications Scientifiques

Dernière publication 24/04/2019

Narciclasine exerts anti-inflammatory actions by blocking leukocyteÐendothelial

The alkaloid narciclasine has been characterized extensively as an anticancer compound. Accumulating evidence suggests that narciclasine has...

Array
(
    [id_prestablog_news] => 1127
    [id_shop] => 1
    [date] => 2019-04-24 00:00:00
    [date_modification] => 2024-02-09 14:15:12
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 2216
    [id_lang] => 2
    [title] => Narciclasine exerts anti-inflammatory actions by blocking leukocyteÐendothelial 
    [paragraph] => Narciclasine exerts anti-inflammatory actions by blocking leukocyteÐendothelial cell interactions and down-regulation of the endothelial TNF receptor 1
    [content] => 

Authors
A Stark, R Schwenk, G Wack, G Zuchtriegel et al


Lab
Institute of Pharmaceutical Biology, Faculty of Biochemistry, Chemistry and Pharmacy, Goethe University Frankfurt, Frankfurt, Germany

Journal
The FASEB Journal

Abstract
The alkaloid narciclasine has been characterized extensively as an anticancer compound. Accumulating evidence suggests that narciclasine has anti-inflammatory potential; however, the underlying mechanism remains poorly understood. We hypothesized that narciclasine affects the activation of endothelial cells (ECs), a hallmark of inflammatory processes, which is a prerequisite for leukocyte-EC interaction. Thus, we aimed to investigate narciclasineÕs action on this process in vivo and to analyze the underlying mechanisms in vitro. In a murine peritonitis model, narciclasine reduced leukocyte infiltration, proinflammatory cytokine expression, and inflammation-associated abdominal pain. Moreover, narciclasine decreased rolling and blocked adhesion and transmigration of leukocytes in vivo. In cultured ECs, narciclasine inhibited the expression of cell adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin and blocked crucial steps of the NF-kappaB activation cascade: NF-kappaB promotor activity, p65 nuclear translocation, inhibitor of kappaB alpha (IkappaBalpha) phosphorylation and degradation, and I_Balpha kinase beta and TGF-betaÐactivated kinase 1 phosphorylation. Interestingly, these effects were based on the narciclasine-triggered loss of TNF receptor 1 (TNFR1). Our study highlights narciclasine as an interesting anti-inflammatory compound that effectively inhibits the interaction of leukocytes with ECs by blocking endothelial activation processes. Most importantly, we showed that the observed inhibitory action of narciclasine on TNF-triggered signaling pathways is based on the loss of TNFR1.

BIOSEB Instruments Used
Dynamic Weight Bearing 2.0 (BIO-DWB-DUAL)

[meta_description] => [meta_keywords] => https://www.fasebj.org/doi/abs/10.1096/fj.201802440R [meta_title] => [link_rewrite] => narciclasine-exerts-anti-inflammatory-actions-by-blocking-leukocyteendothelial-cell-interactions-and-down-regulation-of-the-endothelial-tnf-receptor-1 [actif_langue] => 1 [read] => 957 [count_comments] => 0 [id] => 1127 [categories] => Array ( [93] => Array ( [id_prestablog_categorie] => 93 [title] => Inflammation [link_rewrite] => Inflammation ) [2] => Array ( [id_prestablog_categorie] => 2 [title] => Publications [link_rewrite] => publications ) [24] => Array ( [id_prestablog_categorie] => 24 [title] => Thématiques transversales [link_rewrite] => Thematiques-transversales ) ) [authors] => [paragraph_crop] => Narciclasine exerts anti-inflammatory actions by blocking leukocyteÐendothelial cell [...] [link_for_unique] => 1 [products_liaison] => Array ( [1216] => Array ( [name] => Distribution Pondérale Dynamique 2.0 [description_short] =>

Un système permettant l'analyse de la posture des animaux par la répartition du poids sur chacune des 4 pattes. Le DWB est un test unique dans l'étude de nombreux modèles de douleurs, principalement non évoquée , neuropathique ou encore inflammatoire ainsi que pour les études sur l'osthéoarthrite et divers affections du SNC.

Le nouvelle version DWB2 intègre une nouvelle interface logiciel plus simple avec gestion des listes d'animaux ainsi que de nouveaux algorithmes d'analyse automatique de la posture.

Instrument for ratsInstrument for mice

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://bioseb.com/fr/douleur-spontanee-deficit-de-posture/1216-dynamic-weight-bearing-20.html ) [1877] => Array ( [name] => Dynamic Weight Bearing 2.0 – Module Postural Additionnel [description_short] =>

Étendez votre analyse grâce à des calculs posturaux et locomoteurs avancés

Le système de Distribution Pondérale Dynamique (DWB2) de BIOSEB s’enrichit avec l'ajout du Module Postural. Ce complément logiciel optionnel améliore l’analyse standard de la répartition du poids en intégrant des nouveaux calculs conçus pour l’étude de la posture, de la locomotion et de l’activité des animaux.

Développé en collaboration avec le laboratoire du Dr. Tighilet de l’Université Aix-Marseille - CNRS, le Module Postural améliore votre DWB2 en fournissant des paramètres précieux pour les recherches sur la douleur, les troubles vestibulaires et les maladies neurodégénératives.

Instrument for ratsInstrument for mice

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://bioseb.com/fr/douleur-spontanee-deficit-de-posture/1877-dynamic-weight-bearing-20-module-postural-additionnel.html ) ) ) 1
En lire plus

Filtres

Applications

Dates

<< 1 2 >>